[ET Net News Agency, 3 July 2025] AKESO (09926) rose 13.9% to HK$105.7.
It hits an intra-day high of HK$105.7, hitting a historical high, breaking above the 10-D SMA of HK$95.2, and an intra-day low of HK$93.05. The total shares traded was 26.2 million, with a value of HK$2.64b. The active buy/sell ratio is 67:33, with net buying turnover of HK$898.65m. UBS accounts for greatest net responsive buying turnover of HK$175.16m, with volume weighted average price of HK$101.304. CHINA INV INFO accounts for greatest net responsive selling turnover of HK$294.6m, with volume weighted average price of HK$101. The stock has risen a combined 15% over the past 2 consecutive trading days.
Basic Information| Nominal | 105.700 | % Chg | +13.90% |
| High | 105.700 | Low | 93.050 |
| Shares Tr | 26.2m | Turnover | 2.64b |
| 10-D SMA | 95.200 | %H.V | 53.303 |
| 20-D SMA | 93.645 | VWAP | 100.723 |
| 50-D SMA | 88.542 | RSI14 | 67.068 |
Status: Breaking above the 10-D SMA, hitting a historical high, active buy/sell ratio is 67:33, with net buying turnover of HK$898.65m, rising a combined 15% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| AKESO (09926) | 105.70 | +13.90 |
| SINO BIOPHARM (01177) | 5.49 | +3.00 |
| 3SBIO (01530) | 25.50 | +5.15 |
| EVEREST MED (01952) | 64.85 | +1.73 |
| WUXI XDC (02268) | 43.75 | +4.54 |
| ASCENTAGE-B (06855) | 84.50 | +8.19 |
| SKB BIO-B (06990) | 349.20 | +6.14 |
| ZAI LAB (09688) | 29.15 | +4.67 |
| INNOCARE (09969) | 13.54 | +4.48 |
| REMEGEN (09995) | 58.35 | +5.61 |
(ed)
